Compare CDE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDE | ENOV |
|---|---|---|
| Founded | 1928 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Fluid Controls |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 1.4B |
| IPO Year | 1994 | 2008 |
| Metric | CDE | ENOV |
|---|---|---|
| Price | $19.25 | $23.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $22.40 | ★ $47.38 |
| AVG Volume (30 Days) | ★ 20.3M | 683.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 533.33 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $709,598,000.00 | N/A |
| Revenue This Year | $165.39 | $6.36 |
| Revenue Next Year | $12.10 | $5.31 |
| P/E Ratio | $19.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.21 | $21.00 |
| 52 Week High | $27.77 | $36.82 |
| Indicator | CDE | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 49.55 |
| Support Level | $19.08 | $21.37 |
| Resistance Level | $19.73 | $26.72 |
| Average True Range (ATR) | 0.92 | 1.19 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 29.69 | 34.90 |
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico generating maximum revenue from United States.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.